Latest Regulatory Clearance News

Dundee Precious Metals has published the detailed scheme document for its recommended acquisition of Adriatic Metals, setting the stage for shareholder votes in August 2025. The transaction, subject to regulatory approvals, aims to consolidate two key players in the precious metals mining sector.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.

Ausgold Limited has raised A$35 million through a well-supported placement to accelerate its Katanning Gold Project in Western Australia towards a final investment decision.

OD6 Metals has resolved a regulatory investigation with a minor penalty, paving the way for renewed exploration at its Gulf Creek Copper Project. The company is set to advance drilling campaigns targeting high-grade copper, zinc, and silver mineralisation.

Platinum Asset Management and L1 Capital have agreed to merge, creating a combined entity managing approximately A$16.5 billion in assets. The deal promises strategic diversification, cost synergies, and significant earnings accretion for shareholders.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

Lightning Minerals has initiated site preparations for a Phase 1 drilling campaign at the Mt Turner Gold Project in Queensland, aiming to unlock deeper gold mineralisation beneath historic pits. The move follows a recent funding boost and is part of the company’s proposed acquisition of Lotus Minerals.

Kingston Resources has fulfilled all regulatory conditions to complete the $95 million sale of its Misima Gold Project to Ok Tedi Mining, unlocking an immediate $50 million payment.

AVJennings Limited has secured crucial approvals from Australian and New Zealand regulators for its proposed acquisition by PM Nominees C Pty Ltd, moving the deal closer to completion.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.